Data Presented on New Gastric Balloons for Weight Loss
Louise Gagnon recently interviewed Allurion’s Chief Scientific Officer Shantanu Gaur for her story in General Surgery News on the Elipse Balloon. The article highlights Allurion’s presentation at this year’s International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) World Congress and underscores the key differences between the Elipse Balloon and all other gastric balloons in development. Here’s an excerpt: In an interview with General Surgery News, Dr. Gaur pointed out that the Elipse has distinct advantages over other intragastric balloons. “The difference with our device, compared to other intragastric balloons, is that it does not require endoscopy or anesthesia,” Dr. Gaur said. Click…
A balloon for obesity: an option between medication and surgery?
The Elipse Balloon was recently covered by Melissa Healy of the LA Times in an article entitled A balloon for obesity: an option between medication and surgery? Here is an excerpt: For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it’s a little help, but not enough. And bariatric surgery — a permanent replumbing of the intestinal tract that is expensive and carries the risks of major surgery — feels like a bit too much help. Could a water balloon…
Elipse Pilot Study Results Presented @ Obesity Week
Dr. Evzen Machytka presented the results of Allurion’s human pilot study entitled First Human Experience with a Novel, Swallowed, Self-emptying, and Excreted Intragastric Balloon for Weight Loss at this year’s Obesity Week. Unlike other intragastric balloons for obesity, Allurion’s Elipse Intragastric Balloon does not require endoscopy or anesthesia. The human pilot study in 8 patients demonstrated that the Elipse balloon is safe and feasible and ready for further testing. We would like to congratulate the American Society of Metabolic and Bariatric Surgery and The Obesity Society for organizing another well-attended and informative conference. Allurion is looking forward to Obesity Week 2015! Dr. Evzen…
Allurion Technologies @ Obesity Week
We will be presenting our pilot human clinical data at Obesity Week on November 4. Obesity Week brings together thousands of attendees from all around the world to discuss cutting edge obesity science, advances in clinical management of obesity, and obesity public policy. This year, it is right in our backyard in Boston, MA. Check out the schedule for the event here. We hope that you can join us!
Allurion Technologies @ AGA Tech Summit
Allurion was chosen as one of four innovators by the American Gastroenterological Association (AGA) Center for GI Innovation and Technology to present at the 2014 AGA Technology Summit. The presentation provided an overview of the benefits and limitations of prior-generation intragastric balloons. It also highlighted performance data on Allurion’s Elipse intragastric balloon. A summary of the event was published in the AGA Tech Report.